Nuria Carrillo-Carrasco

Title: Innovator Nuria Carrillo-Carrasco: Pioneering Hyposialylation Disorder Diagnostics

Introduction

Nuria Carrillo-Carrasco is a notable inventor based in Bethesda, MD (US). She has made significant contributions to the field of medical diagnostics, particularly in understanding hyposialylation disorders. Her innovative work has led to advancements in diagnosing and treating these complex conditions.

Latest Patents

Nuria holds a patent related to hyposialylation disorders. The patent outlines methods for diagnosing a hyposialylation disorder and determining the effectiveness of therapeutic agents for treatment. These methods involve measuring the amounts of monosialylated Thomsen-Friedenreich (ST) antigen and non-sialylated Thomsen-Friedenreich antigen (T) in biological samples, such as serum or plasma. A specific ratio of T to ST is used to diagnose the disorder or assess the effectiveness of treatment. This innovative approach has the potential to improve patient outcomes significantly.

Career Highlights

Throughout her career, Nuria has worked with esteemed organizations, including the United States Department of Health and Human Services and Emory University. Her work has been instrumental in advancing the understanding of hyposialylation disorders and developing effective diagnostic methods.

Collaborations

Nuria has collaborated with notable professionals in her field, including Marjan Huizing and William A. Gahl. These collaborations have further enriched her research and contributed to the development of her patented methods.

Conclusion

Nuria Carrillo-Carrasco is a pioneering inventor whose work in hyposialylation disorders has the potential to transform diagnostic practices. Her contributions to medical science highlight the importance of innovation in improving healthcare outcomes.